• OPEN AN ACCOUNT
Indian Indices
Sensex
74,777.05 12.82
( 0.02%)
Global Indices
Nasdaq
52,403.42 -403.65
(-0.76%)
Dow Jones
7,657.83 -36.69
(-0.48%)
Hang Seng
65,089.68 -179.65
(-0.28%)
Nikkei 225
10,664.98 -146.68
(-1.36%)
Forex
USD-INR
94.74 0.23
(0.24%)
EUR-INR
110.11 0.28
(0.26%)
GBP-INR
128.27 0.39
(0.30%)
JPY-INR
0.62 0.01
(0.94%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
23.9
181.53
EPS(TTM)
Face Value()
Div & Yield %
4.77
10
1.05
 

Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13